HCA Healthcare (HCA)
(Delayed Data from NYSE)
$307.76 USD
-1.08 (-0.35%)
Updated May 3, 2024 04:00 PM ET
After-Market: $307.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
HCA Healthcare, Inc. [HCA]
Reports for Purchase
Showing records 261 - 280 ( 281 total )
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Afternoon Call Summary
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Raising Estimates Slightly; Reform Upside More Likely in 2015 & 2016
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Pre-Announces Better than Expected 3Q on Higher Pricing/Acuity
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Increased Patient Acuity, Cost Management Drive Upside
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Pre-Announces Better than Expected 2Q but Details Are Light
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Initiating Coverage with a HOLD Rating
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Health Care Sector Research-Initiating Coverage
Provider: KEYBANC CAPITAL MARKETS
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
4Q Review: Monster EPS Beat; 2012 Guidance Solid; Reiterate Hold on Potential Headline Risk over the next 12 Months
Provider: AURIGA USA
Analyst: LOSEV G
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Change in Accounting for HITECH Revenue; No Change in Fundamentals; Reiterate Buy
Provider: AURIGA USA
Analyst: LOSEV G
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
3Q11 Review: Robust Volume Growth and Cost Management Overshadow Continued Weakness in Cardiac Surgeries
Provider: AURIGA USA
Analyst: LOSEV G
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
Company: HCA Healthcare, Inc.
Industry: Medical - Hospital
2Q Medicare Acuity Drop -- some pressures are fixable relatively quickly, some will take time; but stock is oversold.
Provider: AURIGA USA
Analyst: LOSEV G